It has been established that astrocytes can modulate the pathological process of stroke through multiple pathways and that the same pathological phenomenon may have both beneficial and detrimental effects. For example, glial scarring impedes the spread of tissue damage to healthy tissue but also impedes neural repair function. Because of the complex role of astrocytes in stroke pathology, the development of stroke drugs targeting astrocytes has become more specific and more challenging. Therefore, Ace Neuroscience offers a comprehensive service ranging from identification and validation of astrocyte targets to pharmacological evaluation of astrocyte modulators in stroke to facilitate the study of stroke drugs targeting astrocytes.
Studies have shown that astrocytes can modulate excitotoxicity, oxidative stress, mitochondrial function, and other pathways during the stroke. Because of the complex functions of astrocytes, modulation of astrocytes and thus stroke treatment requires more specificity and targeting of modulators. Therefore, Ace Neuroscience offers a comprehensive service with the aim of finding specific targets.
After screening astrocytes for specific targets in stroke pathology, we provide high-throughput screening platforms to perform high-throughput screening of modulators based on the characteristics of the targets. In parallel, we provide comprehensive services to explore the effects of candidate modulators on astrocytes.
We have validated the effect of modulators on astrocytes. Immediately afterward, we offer a variety of pharmacological activity assessment services to investigate the therapeutic effects of astrocyte modulators on stroke while exploring their specific mechanisms of action and drug metabolism.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.